Aptevo Therapeutics Inc (APVO) stock is down -78.40% over the past 12 months, and Wall Street analysts’ average rating is Strong Buy. InvestorsObserver’s proprietary ranking system gives APVO shares a score of 27 out of a possible 100.

This rank is mainly influenced by a short-term technical rating of 0. APVO’s rank also includes a long-term technical rating of 0. The base rating for APVO is 79. In addition to the average rating from Wall Street analysts, APVO stock has an average price target of $ 52.50. This means that analysts expect the stock to gain 433.54% over the next 12 months.

Copyright © 2021. Portions of this content may be copyrighted by Fresh Brewed Media, Investors Observer and / or O2 Media LLC. All rights reserved. Portions of this content are protected by U.S. Patent Nos. 7,865,496, 7,856,390, and 7,716,116. Investing in stocks, bonds, options, and other financial instruments carries risks and may not be suitable for everyone. The portfolio results are unaudited and are based on different expiration dates of the plant. Terms of Use | Privacy Policy

Ref: https://www.investorsobserver.com